Zomedica Corp.
ZOMDF
$0.041
$0.00194.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.74% | 6.00% | 8.33% | 11.33% | 16.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.74% | 6.00% | 8.33% | 11.33% | 16.23% |
| Cost of Revenue | 6.27% | -2.63% | 4.19% | 7.48% | 19.52% |
| Gross Profit | 9.86% | 10.10% | 10.21% | 13.10% | 14.80% |
| SG&A Expenses | -6.61% | -0.18% | 8.53% | 26.50% | 25.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.40% | 0.74% | 9.75% | 31.70% | 29.80% |
| Operating Income | 12.01% | 3.21% | -10.88% | -50.99% | -41.51% |
| Income Before Tax | -47.84% | -161.67% | -32.56% | -249.26% | -174.87% |
| Income Tax Expenses | 83.45% | 73.71% | 58.12% | 104.33% | -12.38% |
| Earnings from Continuing Operations | -51.99% | -172.43% | -36.06% | -316.46% | -188.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.99% | -172.43% | -36.06% | -316.46% | -188.03% |
| EBIT | 12.01% | 3.21% | -10.88% | -50.99% | -41.51% |
| EBITDA | 17.88% | 9.09% | -6.92% | -54.75% | -41.55% |
| EPS Basic | -51.84% | -171.92% | -35.41% | -314.38% | -186.93% |
| Normalized Basic EPS | 9.22% | -1.06% | -19.05% | -72.44% | -53.73% |
| EPS Diluted | -68.30% | -196.59% | -62.04% | -314.38% | -186.93% |
| Normalized Diluted EPS | 9.22% | -1.06% | -19.05% | -72.44% | -53.73% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |